Tags: Coronavirus | pfixer | gilead | remdesivir | covid

Pfizer Signs Deal to Supply Gilead's Remdesivir for COVID-19

Pfizer Signs Deal to Supply Gilead's Remdesivir for COVID-19
(Mohamed Ahmed Soliman | Dreamstime.com)

Friday, 07 August 2020 08:54 AM

Pfizer Inc. said on Friday it signed a multi-year agreement to manufacture Gilead Sciences Inc's antiviral drug remdesivir for COVID-19 patients in a bid to ramp up its supply.

The company (PFE) would use its Kansas plant to manufacture the drug, it said.

The drug is one of only two that have demonstrated an ability to help hospitalized COVID-19 patients in formal clinical trials.

On Thursday, Gilead said its manufacturing network for the drug had grown to more than 40 companies in North America, Europe and Asia to add capacity.

Britain's Hikma Pharmaceuticals has started manufacturing remdesivir at its Portugal plant, the British company's chief executive officer said on Friday.

© 2020 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
Companies
Pfizer Inc said on Friday it signed a multi-year agreement with Gilead Sciences Inc to manufacture and supply the company's antiviral drug remdesivir for COVID-19 patients.
pfixer, gilead, remdesivir, covid
110
2020-54-07
Friday, 07 August 2020 08:54 AM
Newsmax Media, Inc.
 
Newsmax TV Live

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved